Jonathan Sackner-Bernstein,Andrew L. Pecora,Robert A. Preti
申请号:
US13792368
公开号:
US20140056842A1
申请日:
2013.03.11
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The described invention provides cellular therapeutic approaches for treating a vascular insufficiency following a traumatic injury to head or spine that results in an injury to brain, spinal cord, or both by administering a therapeutic amount of an isolated, nonexpanded population of autologous mononuclear cells comprising a subpopulation of CD34+ cells, which further contains a subpopulation of potent SDF-1 mobile CD34+/CXCR-4 cells that have CXCR-4-mediated chemotactic activity.